These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17003330)

  • 1. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice.
    Gray SL; Nora ED; Grosse J; Manieri M; Stoeger T; Medina-Gomez G; Burling K; Wattler S; Russ A; Yeo GS; Chatterjee VK; O'Rahilly S; Voshol PJ; Cinti S; Vidal-Puig A
    Diabetes; 2006 Oct; 55(10):2669-77. PubMed ID: 17003330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARgamma) function.
    Gray SL; Dalla Nora E; Backlund EC; Manieri M; Virtue S; Noland RC; O'Rahilly S; Cortright RN; Cinti S; Cannon B; Vidal-Puig A
    Endocrinology; 2006 Dec; 147(12):5708-14. PubMed ID: 16980437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction.
    Pendse AA; Johnson LA; Tsai YS; Maeda N
    Diabetes; 2010 Nov; 59(11):2890-7. PubMed ID: 20724579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA; Johnson LA; Kim HS; McNair M; Nipp CT; Wilhelm C; Maeda N
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.
    Gayet C; Leray V; Saito M; Siliart B; Nguyen P
    Br J Nutr; 2007 Sep; 98(3):497-503. PubMed ID: 17475082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orphan nuclear receptor small heterodimer partner is required for thiazolidinedione effects in leptin-deficient mice.
    Tseng HT; Park YJ; Lee YK; Moore DD
    J Biomed Sci; 2015 May; 22(1):30. PubMed ID: 25951943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P465L-PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates.
    Rodriguez-Cuenca S; Carobbio S; Barceló-Coblijn G; Prieur X; Relat J; Amat R; Campbell M; Dias AR; Bahri M; Gray SL; Vidal-Puig A
    Diabetes Obes Metab; 2018 Oct; 20(10):2339-2350. PubMed ID: 29790245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
    Tsai YS; Kim HJ; Takahashi N; Kim HS; Hagaman JR; Kim JK; Maeda N
    J Clin Invest; 2004 Jul; 114(2):240-9. PubMed ID: 15254591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor γ-dependent regulation of lipolytic nodes and metabolic flexibility.
    Rodriguez-Cuenca S; Carobbio S; Velagapudi VR; Barbarroja N; Moreno-Navarrete JM; Tinahones FJ; Fernandez-Real JM; Orešic M; Vidal-Puig A
    Mol Cell Biol; 2012 Apr; 32(8):1555-65. PubMed ID: 22310664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.
    Medina-Gomez G; Gray SL; Yetukuri L; Shimomura K; Virtue S; Campbell M; Curtis RK; Jimenez-Linan M; Blount M; Yeo GS; Lopez M; Seppänen-Laakso T; Ashcroft FM; Oresic M; Vidal-Puig A
    PLoS Genet; 2007 Apr; 3(4):e64. PubMed ID: 17465682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
    Takasawa K; Kubota N; Terauchi Y; Kadowaki T
    Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat Mass Reduction With Adipocyte Hypertrophy and Insulin Resistance in Heterozygous PPARγ Mutant Rats.
    Gumbilai V; Ebihara K; Aizawa-Abe M; Ebihara C; Zhao M; Yamamoto Y; Mashimo T; Hosoda K; Serikawa T; Nakao K
    Diabetes; 2016 Oct; 65(10):2954-65. PubMed ID: 27381370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance.
    Jones JR; Barrick C; Kim KA; Lindner J; Blondeau B; Fujimoto Y; Shiota M; Kesterson RA; Kahn BB; Magnuson MA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6207-12. PubMed ID: 15833818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.
    Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T
    J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.
    Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE
    Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy.
    Liu L; Jiang Q; Wang X; Zhang Y; Lin RC; Lam SM; Shui G; Zhou L; Li P; Wang Y; Cui X; Gao M; Zhang L; Lv Y; Xu G; Liu G; Zhao D; Yang H
    Diabetes; 2014 Jul; 63(7):2320-31. PubMed ID: 24622797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors.
    Krempler F; Breban D; Oberkofler H; Esterbauer H; Hell E; Paulweber B; Patsch W
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):443-9. PubMed ID: 10669642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression.
    Xiong J; Sun P; Wang Y; Hua X; Song W; Wang Y; Wu J; Yu W; Liu G; Chen L
    Diabetologia; 2020 Feb; 63(2):338-350. PubMed ID: 31776610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.